CATALOGO DEI PRODOTTI DELLA RICERCA

LANZAFAME, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.321
EU - Europa 2.948
AS - Asia 2.092
SA - Sud America 304
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 69
OC - Oceania 7
Totale 8.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.225
RU - Federazione Russa 1.151
SG - Singapore 871
CN - Cina 597
GB - Regno Unito 529
IT - Italia 262
BR - Brasile 250
SE - Svezia 195
VN - Vietnam 184
DE - Germania 176
IE - Irlanda 161
HK - Hong Kong 152
FR - Francia 150
FI - Finlandia 131
KR - Corea 66
CA - Canada 49
BD - Bangladesh 45
UA - Ucraina 43
IN - India 34
JP - Giappone 34
ZA - Sudafrica 26
AR - Argentina 25
MX - Messico 24
PL - Polonia 24
NL - Olanda 22
CZ - Repubblica Ceca 21
TR - Turchia 20
ID - Indonesia 18
IQ - Iraq 15
NG - Nigeria 15
BE - Belgio 14
ES - Italia 12
CO - Colombia 11
AT - Austria 10
BF - Burkina Faso 8
UZ - Uzbekistan 8
LT - Lituania 7
PK - Pakistan 7
SA - Arabia Saudita 7
CL - Cile 6
PH - Filippine 6
RO - Romania 6
AU - Australia 5
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
GR - Grecia 4
GT - Guatemala 4
JM - Giamaica 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
NI - Nicaragua 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BJ - Benin 1
CD - Congo 1
DZ - Algeria 1
GY - Guiana 1
HN - Honduras 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
UG - Uganda 1
Totale 8.742
Salva come PNG Salva come JPEG
Città #
Singapore 492
Southend 416
Moscow 409
Chandler 389
Ashburn 301
San Jose 293
Jacksonville 245
Woodbridge 234
Dallas 196
Dublin 160
Hong Kong 150
Ann Arbor 140
Council Bluffs 128
Beijing 122
Verona 94
New York 79
Los Angeles 76
The Dalles 72
Ho Chi Minh City 58
Lawrence 53
Princeton 53
Helsinki 48
Houston 46
Jinan 45
Munich 45
Nanjing 44
Shenyang 43
Wilmington 43
Hanoi 37
Santa Clara 35
Tokyo 31
São Paulo 29
Buffalo 25
Warsaw 24
Hebei 21
Denver 20
London 20
Montreal 20
Orem 20
Turku 20
Atlanta 19
Frankfurt am Main 19
Tianjin 19
Bologna 18
Brno 18
Boardman 16
Redondo Beach 16
Seoul 16
Toronto 16
Ningbo 15
Phoenix 15
Zhengzhou 15
Abuja 14
Brussels 14
Haikou 14
Johannesburg 14
Bloomsbury 13
Sindelfingen 13
Changsha 12
Milan 12
Amsterdam 11
Chennai 11
Guangzhou 11
Hangzhou 11
Nanchang 11
San Francisco 11
Seattle 11
Taizhou 11
Boston 10
Columbus 10
Jiaxing 10
Norwalk 10
Redmond 10
Stockholm 10
Brooklyn 9
Chicago 9
Jakarta 9
Redwood City 9
Rio de Janeiro 9
Da Nang 8
Dong Ket 8
Fuzhou 8
Haiphong 8
Ouagadougou 8
Baghdad 7
Clearwater 7
Lanzhou 7
Manchester 7
Nuremberg 7
Poplar 7
Tashkent 7
Belo Horizonte 6
City of London 6
Falls Church 6
Mexico City 6
Mumbai 6
Taiyuan 6
Washington 6
Curitiba 5
Madrid 5
Totale 5.418
Salva come PNG Salva come JPEG
Nome #
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinic 246
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 243
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection. 219
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 217
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 214
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 208
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 200
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 193
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 189
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 187
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 187
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 186
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 184
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 181
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 179
Primary cutaneous cryptococcosis in a HIV infested patient: case report. 177
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 177
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 175
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 175
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 174
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 172
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 168
No improvement of lipodystrophy syndrome in an HIV-infected patient. 167
Can we really identify HIV-1 long-term nonprogressors? 166
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 164
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 164
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 162
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 162
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 162
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 158
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 158
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 150
Antiretroviral therapy in low-resource settings 149
Oxaliplatin Based Chemotherapy and Concomitant Highly Active Antiretroviral Therapy in the Treatment of 24 Patients with Colorectal Cancer and HIV Infection 148
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 147
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 146
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 143
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. 137
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 136
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 135
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 134
The treatment of latent TB infection in HIV-positive people: the Verona experience 131
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 131
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose 129
Inflammatory pseudotumor of lymph nodes. 128
Raltegravir: is a 400 mg once-daily dose enough? 124
The major genetic determinants of HIV-1 control affect HLA Class I Peptide presentation 124
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 123
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 123
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital 117
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 109
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 107
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose. 86
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 85
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 84
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs-Experience From Northern Italy 35
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 32
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 29
Totale 8.836
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.896
article - articoli 29.584
book - libri 0
conference - conferenze 312
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022445 0 151 4 66 6 8 5 22 26 15 32 110
2022/20231.035 58 137 83 164 100 256 3 71 122 6 20 15
2023/2024486 26 45 52 39 63 84 6 26 6 28 63 48
2024/20251.148 59 81 37 175 59 27 66 39 184 71 105 245
2025/20263.765 256 200 188 637 1.038 258 312 165 341 230 60 80
2026/2027119 46 73 0 0 0 0 0 0 0 0 0 0
Totale 8.836